Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Nov;8(5):574–580. doi: 10.1128/aac.8.5.574

Effect of Peritoneal Dialysis on Serum Levels of Tobramycin and Clindamycin

Robert F Malacoff 1, Frederic O Finkelstein 1, Vincent T Andriole 1
PMCID: PMC429424  PMID: 1211913

Abstract

The pharmacokinetics of tobramycin and clindamycin were examined in patients undergoing peritoneal dialysis for chronic renal failure. Peak serum levels of tobramycin in functionally anephric patients were less than expected, probably secondary to a larger volume of distribution. Peritoneal dialysis resulted in a significant clearance of tobramycin, with a resultant reduction in serum half-life. The present data suggest that, if bactericidal serum levels of tobramycin are to be maintained in patients undergoing peritoneal dialysis, a parenteral loading dose be administered, followed by either (i) an identical dose every third half-life or (ii) one-half the loading dose every half-life. However, optimal therapy is best achieved by monitoring serum levels to insure appropriate drug dosage. Peak serum levels of clindamycin in functionally anephric patients were approximately twofold greater than those expected in normals after an identical parenteral dose. It is, therefore, recommended that the administered dose of this agent in functionally anephric patients be one-half of that required to produce desired peak serum levels in patients without renal impairment. Peritoneal clearance of clindamycin during dialysis was shown to be essentially zero, indicating that dialysis does not affect clindamycin disposition.

Full text

PDF
574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins R. C., Mion C., Despaux E., Nguyen-Van-Hai, Julien C., Mion H. Peritoneal transfer of kanamycin and its use in peritoneal dialysis. Kidney Int. 1973 Jun;3(6):391–396. doi: 10.1038/ki.1973.61. [DOI] [PubMed] [Google Scholar]
  2. Black H. R., Finkelstein F. O., Lee R. V. The treatment of peritonitis in patients with chronic indwelling catheters. Trans Am Soc Artif Intern Organs. 1974;20A:115–119. [PubMed] [Google Scholar]
  3. Cutler R. E., Gyselynck A. M., Fleet W. P., Forrey A. W. Correlation of serum creatinine concentration and gentamicin half-life. JAMA. 1972 Feb 21;219(8):1037–1041. [PubMed] [Google Scholar]
  4. DeHaan R. M., Metzler C. M., Schellenberg D., Vandenbosch W. D. Pharmacokinetic studies of clindamycin phosphate. J Clin Pharmacol. 1973 May-Jun;13(5):190–209. doi: 10.1002/j.1552-4604.1973.tb00208.x. [DOI] [PubMed] [Google Scholar]
  5. Geddes A. M., Bridgwater F. A., Williams D. N., Oon J., Grimshaw G. J. Clinical and bacteriological studies with clindamycin. Br Med J. 1970 Jun 20;2(5711):703–704. doi: 10.1136/bmj.2.5711.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodwin N. J., Friedman E. A. The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels. Ann Intern Med. 1968 May;68(5):984–994. doi: 10.7326/0003-4819-68-5-984. [DOI] [PubMed] [Google Scholar]
  7. Gordon R. C., Regamey C., Kirby W. M. Serum protein binding of the aminoglycoside antibiotics. Antimicrob Agents Chemother. 1972 Sep;2(3):214–216. doi: 10.1128/aac.2.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenberg P. A., Sanford J. P. Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate. Ann Intern Med. 1967 Mar;66(3):465–470. doi: 10.7326/0003-4819-66-3-465. [DOI] [PubMed] [Google Scholar]
  9. Henderson L. W., Nolph K. D. Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid. J Clin Invest. 1969 Jun;48(6):992–1001. doi: 10.1172/JCI106080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jackson G. G. Current therapeutics. 234. Gentamicin. Practitioner. 1967 Jun;198(188):855–866. [PubMed] [Google Scholar]
  11. Joshi A. M., Stein R. M. Altered serum clearance of intravenously administered clindamycin phosphate in patients with uremia. J Clin Pharmacol. 1974 Feb-Mar;14(2):140–144. doi: 10.1002/j.1552-4604.1974.tb02304.x. [DOI] [PubMed] [Google Scholar]
  12. Karnovsky M. J. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol. 1967 Oct;35(1):213–236. doi: 10.1083/jcb.35.1.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lockwood W. R., Bower J. D. Tobramycin and gentamicin concentrations in the serum of normal and anephric patients. Antimicrob Agents Chemother. 1973 Jan;3(1):125–129. doi: 10.1128/aac.3.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Riegelman S., Loo J. C., Rowland M. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci. 1968 Jan;57(1):117–123. doi: 10.1002/jps.2600570123. [DOI] [PubMed] [Google Scholar]
  15. Ruedy J. The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease. Can Med Assoc J. 1966 Feb 5;94(6):257–261. [PMC free article] [PubMed] [Google Scholar]
  16. Simon V. K., Mösinger E. U., Malerczy V. Pharmacokinetic studies of tobramycin and gentamicin. Antimicrob Agents Chemother. 1973 Apr;3(4):445–450. doi: 10.1128/aac.3.4.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wagner J. G., Novak E., Patel N. C., Chidester C. G., Lummis W. L. Absorption, excretion and half-life of clinimycin in normal adult males. Am J Med Sci. 1968 Jul;256(1):25–37. doi: 10.1097/00000441-196807000-00004. [DOI] [PubMed] [Google Scholar]
  18. Weinstein A. J., Karchmer A. W., Moellering R. C., Jr Tobramycin concentrations during peritoneal dialysis. Antimicrob Agents Chemother. 1973 Oct;4(4):432–434. doi: 10.1128/aac.4.4.432. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES